From Wikipedia, the free encyclopedia
GRM7
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases GRM7, GLUR7, GPRC1G, MGLU7, MGLUR7, PPP1R87, glutamate metabotropic receptor 7, NEDSHBA
External IDs OMIM: 604101; MGI: 1351344; HomoloGene: 20233; GeneCards: GRM7; OMA: GRM7 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000844
NM_181874
NM_181875

NM_177328
NM_001346640
NM_177970

RefSeq (protein)

NP_000835
NP_870989

NP_001333569
NP_796302

Location (UCSC) Chr 3: 6.77 – 7.74 Mb Chr 6: 110.62 – 111.54 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Metabotropic glutamate receptor 7 is a protein that in humans is encoded by the GRM7 gene. [5] [6] [7]

Function

L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternative splice variants of GRM8 have been described but their full-length nature has not been determined. [7]

Glutamate has lower affinity for mGluR7 than the other metabotropic glutamate receptors and it has been suggested that mGluR7 may have a regulatory role to dampen the effects of excessive glutamate levels. [8]

Ligands

Agonists

  • LSP2-9166: mixed agonist at mGluR4 and mGluR7

Antagonists

Negative allosteric modulators

Interactions

Metabotropic glutamate receptor 7 has been shown to interact with PICK1. [14]

Clinical

Mutations in both copies have been associated with developmental and epileptic encephalopathy, microcephaly, hypomyelination and cerebral atrophy. [15]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000196277Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000056755Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Okamoto N, Hori S, Akazawa C, Hayashi Y, Shigemoto R, Mizuno N, Nakanishi S (January 1994). "Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction". The Journal of Biological Chemistry. 269 (2): 1231–1236. doi: 10.1016/S0021-9258(17)42247-2. hdl: 2433/182290. PMID  8288585.
  6. ^ Makoff A, Pilling C, Harrington K, Emson P (August 1996). "Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS". Brain Research. Molecular Brain Research. 40 (1): 165–170. doi: 10.1016/0169-328X(96)00110-6. PMID  8840028.
  7. ^ a b "Entrez Gene: GRM7 glutamate receptor, metabotropic 7".
  8. ^ Fisher NM, Seto M, Lindsley CW, Niswender CM (2018). "Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders". Frontiers in Molecular Neuroscience. 11: 387. doi: 10.3389/fnmol.2018.00387. PMC  6206046. PMID  30405350.
  9. ^ Li X, Gardner EL, Xi ZX (March 2008). "The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats". Neuropharmacology. 54 (3): 542–551. doi: 10.1016/j.neuropharm.2007.11.005. PMC  2410088. PMID  18155073.
  10. ^ a b Palucha A, Klak K, Branski P, van der Putten H, Flor PJ, Pilc A (November 2007). "Activation of the mGlu7 receptor elicits antidepressant-like effects in mice". Psychopharmacology. 194 (4): 555–562. doi: 10.1007/s00213-007-0856-2. PMID  17622518. S2CID  22011436.
  11. ^ Pelkey KA, Yuan X, Lavezzari G, Roche KW, McBain CJ (January 2007). "mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082". Neuropharmacology. 52 (1): 108–117. doi: 10.1016/j.neuropharm.2006.07.020. PMID  16914173. S2CID  23372757.
  12. ^ Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, Kurihara H, et al. (October 2007). "In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists". The Journal of Pharmacology and Experimental Therapeutics. 323 (1): 147–156. doi: 10.1124/jpet.107.124701. PMID  17609420. S2CID  10402176.
  13. ^ Kalinichev M, Rouillier M, Girard F, Royer-Urios I, Bournique B, Finn T, et al. (March 2013). "ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterization". The Journal of Pharmacology and Experimental Therapeutics. 344 (3): 624–636. doi: 10.1124/jpet.112.200915. PMID  23257312. S2CID  5774001.
  14. ^ Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S (October 2000). "PICK1 interacts with and regulates PKC phosphorylation of mGLUR7". The Journal of Neuroscience. 20 (19): 7252–7257. doi: 10.1523/JNEUROSCI.20-19-07252.2000. PMC  6772771. PMID  11007882.
  15. ^ Marafi D, Mitani T, Isikay S, Hertecant J, Almannai M, Manickam K, et al. (May 2020). "Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy". Annals of Clinical and Translational Neurology. 7 (5): 610–627. doi: 10.1002/acn3.51003. PMC  7261753. PMID  32286009.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.